DUBLIN--(BUSINESS WIRE)--The "At-Home Blood Collection and Micro Sampling Devices Market by Type of Blood Sample State, Method of Sample Collection, Device Usage, Area of Application, and Key Geographical Regions - Industry Trends and Global Forecasts, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
Post the onset of the COVID-19 pandemic, there has been a decline in the number of patients visiting laboratories for sample collection and testing. Owing to the risk of infection associated with such places, several patients postponed their routine tests and medical checkups, in order to avoid the spread of the disease. In fact, an average decline of approximately 40% in phlebotomy appointments was reported by various laboratories across the globe.
The aforementioned concerns have encouraged stakeholders to develop novel devices and technologies that can enable patients to self-collect their blood samples at-home, to monitor their health remotely. Over 80% of the self-blood collecting devices that we came across during our research have already received marketing approval.
In 2021, TAP II and Tasso-M20 self-blood collecting devices received the CE mark from the European Commission. Further, recently, Symbiotica received emergency use authorization by the USFDA for its proprietary at-home COVID-19 serology test kit, which has been demonstrated to be capable of detecting the presence of SARS-CoV-2 using dried blood spot samples.
The at-home blood collection and micro sampling devices market is fragmented, featuring a mix of start-ups/small companies and mid-sized firms. Interestingly, over 40% of the start-ups engaged in this domain have been established since 2014.
Furthermore, large firms are actively acquiring small industry players in order to either consolidate their existing capabilities or enter this niche domain. Consequently, there has been a significant increase in the partnership activity related to at-home blood collection devices, over the past few years. In addition, both public and private investors have invested a sum of more than USD 640 million in this domain, since 2014.
Given the rising adoption and preference for at-home and self-blood collection approaches, coupled to the ongoing efforts of device developers and manufacturers to further expand their respective offerings, the at-home blood collection and micro sampling devices market is likely to witness significant growth in the future.
Scope of the Report
The report features an extensive study of the current market landscape and the likely adoption of at-home self-blood collection and micro sampling devices, over the next decade. The study features a detailed analysis of the key drivers and trends related to this evolving domain.
Key Questions Answered
- Who are the key players engaged in the development of at-home self-blood collection and micro sampling devices?
- Which are the most popular at-home self-blood collection and micro sampling devices available in the market?
- What types of partnership models are commonly being adopted by stakeholders in this industry?
- Who are the key investors that have actively made investments in this domain?
- How is the intellectual property landscape in this field likely to evolve in the foreseen future?
- What is relative competitiveness of different at-home blood collection and micro sampling devices?
- How much cost can be saved by using at-home blood collection and micro sampling devices?
-
How is the current and future market opportunity likely to be distributed across key market segments?
Key Topics Covered:
INTRODUCTION
- Overview of At-Home Blood Collection and Micro Sampling Devices
- Applications of Blood Sampling and Testing
- Types of Blood Sampling
- Benefits of At-Home Blood Collection
- Methods Used for At-Home Blood Collection
- Types of At-Home Blood Collection and Micro Sampling Devices
- Future Perspectives
MARKET OVERVIEW
- At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape
- At-Home Blood Collection and Micro Sampling Devices: List of Developers
- Most Active Players: Analysis by Number of Products
PRODUCT COMPETITIVENESS ANALYSIS
COMPANY PROFILES
- EUROIMMUN
- Everlywell
- Labcorp
- Labonovum
- Lameditech
- Quest Diagnostics
- Spot On Sciences
- Tasso
- Weavr Health
- YourBio Health
PATENT ANALYSIS
- At-Home Blood Collection and Micro Sampling Devices: Patent Analysis
PARTNERSHIPS
- Partnership Models
- At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
FUNDING AND INVESTMENT ANALYSIS
- At-Home Blood Collection and Micro Sampling Devices: Funding and Investment Analysis
COST SAVING ANALYSIS
- Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices
For more information about this report visit https://www.researchandmarkets.com/r/s1vvmx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
